Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,590 | 106,520 | 139,770 | 24,660 | 40 |
| Marketable Securities | 3,500 | 15,030 | 0 | 0 | 0 |
| Receivables | 130 | 130 | 3 | 70 | 0 |
| Other current assets | 470 | 470 | 507 | 250 | 1,640 |
| TOTAL | $91,690 | $122,150 | $140,280 | $24,980 | $1,680 |
| Non-Current Assets | |||||
| PPE Net | 4,240 | 2,310 | 250 | 60 | 100 |
| Investments And Advances | 0 | 2,730 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 1,980 | 0 | 0 | 0 |
| TOTAL | $4,240 | $7,020 | $250 | $60 | $100 |
| Total Assets | $95,930 | $129,190 | $140,530 | $25,050 | $1,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 490 | 530 | 320 | 560 | 270 |
| Accrued Expenses | 3,530 | 1,310 | 100 | 410 | 60 |
| Other current liabilities | 0 | 0 | 8 | 60 | 260 |
| TOTAL | $4,020 | $1,850 | $440 | $1,040 | $600 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,020 | $1,850 | $440 | $1,040 | $600 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 3 | 3 | 2 | 2 |
| Retained earnings | -78,900 | -42,400 | -2,090 | -1,700 | -5,460 |
| Other shareholders' equity | -4 | -3 | -3 | -2 | -2 |
| TOTAL | $91,900 | $127,340 | $140,090 | $24,000 | $1,170 |
| Total Liabilities And Equity | $95,920 | $129,190 | $140,530 | $25,040 | $1,770 |